Logo

Benitec Licenses ddRNAi Technology to Genoway of France to Create Transgenic Animal Models

Mar 22, 2005

NEW YORK, March 22 (GenomeWeb News) - Benitec has licensed its DNA-directed RNA interference technology to Genoway of France, Benitec said today.

 

Under the non-exclusive license, Genoway, based on Lyon, may develop transgenic animals using Benitec's ddRNAi technology. Benitec will receive an upfront license fee and ongoing royalties.

 

Genoway provides mouse and rat models for basic research and drug discovery and has already been using RNAi technology in vivo.

Breaking News
The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.